Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Bone and Joint Health Markers in Persons with Hemophilia A (PwHA) Treated with Emicizumab in HAVEN 3

Anna Kiialainen, PhD, Markus Niggli, PhD, Christine L. Kempton, MD MSc, Giancarlo Castaman, MD, Tiffany Y. Chang, MD MAS, Ido Paz-Priel, MD, Joanne I Adamkewicz, PhD, Gallia G. Levy, MD PhD

Blood (2019) 134 (Supplement_1): 626.

https://doi.org/10.1182/blood-2019-123689

Published: 2019

Journal Articles

Impact of Daratumumab Monotherapy on Bone Parameters in Patients with Relapsed and/or Refractory Multiple Myeloma Who Have Received at Least 2 Prior Lines of Therapy Including Lenalidomide and a Proteasome Inhibitor; Interim Analysis of a Phase 2 Study (the REBUILD Study)

Evangelos Terpos, MD PhD, Eftathios Kastritis, Evdoxia Hatjiharissi, Eirini Katodritou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Evgenia Verrou, MD, Maria Gavriatopoulou, MD, Alexandros Leonidakis, PhD, Ioannis Ntanasis-Stathopoulos, MD, Sosana Delimpasi, MD, Marie-Christine Kyrtsonis, MD PhD, Maria Papaioannou, Argiris Symeonidis, MD PhD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 1837.

https://doi.org/10.1182/blood-2019-124638

Published: 2019

Journal Articles

Bortezomib Overcomes Poor Prognosis Conferred By High Sictp in Untreated Plasma Cell Disorders

Akira Honda, MD PhD, Yu Oyama, MD, Kazuhiro Toyama, MD PhD, Mineo Kurokawa, MD PhD

Blood (2019) 134 (Supplement_1): 5492.

https://doi.org/10.1182/blood-2019-129324

Published: 2019

Journal Articles

Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Phase 1 Study

Seth E Karol, MD, Todd M Cooper, DO, Henrique Bittencourt, Lia Gore, MD, Maureen M O'Brien, MD, Christopher Fraser, MD, Marion Gambart, MD, Gunnar Cario, MD PhD, Christian Michel Zwaan, MD PhD, Jean-Pierre Bourquin, MD PhD, Mignon L. Loh, MD, Hubert Caron, MD PhD, Betty Prine, Ahmed Hamed Salem, PhD FCP, Kristina Unnebrink, Bo Tong, PhD, Tammy Palenski, PhD, Andrew E. Place, MD PhD

Blood (2019) 134 (Supplement_1): 2649.

https://doi.org/10.1182/blood-2019-129805

Published: 2019

Journal Articles

Exosomes Play a Key Role in Multiple Myeloma Bone Disease and Tumor Development

Sylvia Faict, MD, Josephine Muller, PhD, Kim De Veirman, PhD, Ken Maes, Elke De Bruyne, PhD, Rik Schots, Jo Caers, MD PhD, Karin Vanderkerken, PhD, Eline Menu, PhD

Blood (2018) 132 (Supplement 1): 4484.

https://doi.org/10.1182/blood-2018-99-112428

Published: 2018

Journal Articles

Decreased Skeletal Health Negatively Impacts Quality of Life of People with Hemophilia

Galen Goldscheitter, BS, BA, Susan Lattimore, Jason A Taylor, MD PhD

Blood (2018) 132 (Supplement 1): 1207.

https://doi.org/10.1182/blood-2018-99-113086

Published: 2018

Journal Articles

A Novel Ex-Vivo Model of Prolonged Osteoblast Suppression in Multiple Myeloma

Noriyoshi Kurihara, DDS, PhD, Yasuhisa Ohata, MD PhD, Gabriel M. Pagnotti, PhD, John Chirgwin, PhD, G David Roodman, MD PhD

Blood (2017) 130 (Supplement 1): 4360.

https://doi.org/10.1182/blood.V130.Suppl_1.4360.4360

Published: 2017

Journal Articles

Navigating the Changing Multiple Myeloma (MM) Treatment Landscape: Real-World Data on Clinical Practice Patterns in 287 MM Patients Treated in and Outside German DSMM (Deutsche Studiengruppe Multiples Myelom) Study Group Trials

Laura Gengenbach, Heike Reinhardt, PhD, Stefanie Ajayi, Pharmacist, Magdalena Szymaniak-Vits, Pharmacist, Martin Köhler, MSc, Stefan J. Müller, PharmD, Sandra M. Dold, MSc, Martin J. Hug, PhD, Markus Ruch, Martin Boeker, PD, Hermann Einsele, Justus Duyster, Ralph Wäsch, MD, Monika Engelhardt

Blood (2017) 130 (Supplement 1): 3105.

https://doi.org/10.1182/blood.V130.Suppl_1.3105.3105

Published: 2017

Journal Articles

Clinical Predictors of Venous Thromboembolism during Therapy for Childhood Acute Lymphoblastic Leukemia

Marion K Mateos, MBBS FRACP, Toby N. Trahair, MBBS FRACP PhD, Chelsea Mayoh, BSc, Pasquale M Barbaro, MBBS FRACP FRCPA, Rosemary Sutton, BSc PhD, Tamas Revesz, MD PhDD.Sc FRACP FRCPA, Draga Barbaric, MBBS FRACP, Jodie Giles, Frank Alvaro, MBBS, FRACP, Francoise Mechinaud, MD FRACP, Daniel Catchpoole, BSc PhDFFSc(RCPA), Rishi S Kotecha, MB ChB FRACP PhD, Luciano Dalla-Pozza, MB BS FRACP, Glenn M Marshall, MBBS, MD FRACP

Blood (2016) 128 (22): 1182.

https://doi.org/10.1182/blood.V128.22.1182.1182

Published: 2016

Journal Articles

Assessment of the Parameters of Myeloma Bone Disease Signaling to the Extent of Skeletal Involvement, Bone Mineral Turnover and Activity of Multiple Myeloma

Jiri Minarik, Zuzana Hermanova, Pavla Petrova, Jana Zapletalova, Jan Hrbek, Petra Pusciznova, Jaroslav Bacovsky, Tomas Pika, Miroslav Herman, Vlastimil Scudla

Blood (2015) 126 (23): 1754.

https://doi.org/10.1182/blood.V126.23.1754.1754

Published: 2015

Journal Articles

The Clinical Utility of Bone Resorption and Bone Formation Markers in Multiple Myeloma

Shahdabul Faraz, B.S., Roger N Pearse, MD PhD, Sujitha Yadlapati, MBBS, David Jayabalan, BSMS, MSc, Adriana C Rossi, MD MHS, Tomer M Mark, MD MSc, Ruben Niesvizky, MD, Joseph Lane, MD

Blood (2015) 126 (23): 5373.

https://doi.org/10.1182/blood.V126.23.5373.5373

Published: 2015

Journal Articles

Differential Diagnosis of Hereditary and Acquired Thrombocytopenia By the Immature Platelet Fraction and Thrombopoietin Levels

Fabio Luiz Bandeira Ferreira, Marina Pereira Colella, MD PhD, Samuel de Souza Medina, MD, Maiara Marx Luz Fiusa, Loredana Nilkenes Gomes da Costa, Carolina Costa-Lima, MD, Fernanda Andrade Orsi, MDPhD, Joyce Maria Annichino-Bizzacchi, MD PhD, Kleber Yotsumoto Fertrin, MD PhD, Maria de Fatima Pereira Gilberti, MD, Margareth C Ozelo, Erich Vinicius De Paula, MD PhD

Blood (2015) 126 (23): 1049.

https://doi.org/10.1182/blood.V126.23.1049.1049

Published: 2015

Journal Articles

Retrospective Analysis of Minimal Residual Disease-Guided Preemptive Treatment in Patients with AML and MDS - the SAL Study Group Experience

Ekaterina Bulycheva, MD, Jiri Mayer, Prof., MD, William Hermann Krüger, MD PhD, Peter Dreger, MD, Anna Mies, Zuzana Sustkova, MD, Zdenek Racil, MD, Jirina Prochazkova, MD, Eva Walter, MD, Carsten Hirt, Mark Ringhoffer, MD, Wolfgang E Berdel, MD, Hubert Serve, MD, Christoph Rollig, Katja Sockel, MD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Christian Thiede, MD PhD, Uwe Platzbecker, MD

Blood (2015) 126 (23): 3817.

https://doi.org/10.1182/blood.V126.23.3817.3817

Published: 2015

Journal Articles

The Role of RANKL/Osteoprotegerin and Wnt Signaling Pathways in the Development of Osteoporosis in Patients with Hemophilia

Panagiotis Anagnostis, Sofia Vakalopoulou, Dimitrios Christoulas, Spyridon Karras, Athanasios Papatheodorou, Eirini Katodritou, Panagiotis Kokkoris, Vasilia Garipidou, Evangelos Terpos

Blood (2015) 126 (23): 2284.

https://doi.org/10.1182/blood.V126.23.2284.2284

Published: 2015

Journal Articles

Differential Influence of Lung Cancer Stage, Time from Diagnosis and Chemotherapy on Plasma and Cellular Biomarkers of Hypercoagulability. the Roadmap Study

Ilias Evmorfiadis, Paraskevi Boura, Aurélie Rousseau, Ariadni Charpidou, Giannis Giozos, Patrick Van Dreden, PhD, Konstantinos Syrigos, Anastasia Spanoudaki, Matthieu Grusse, Ismail Elalamy, MD, Grigorios T. Gerotziafas, Dr

Blood (2014) 124 (21): 4253.

https://doi.org/10.1182/blood.V124.21.4253.4253

Published: 2014

Journal Articles

Quantitation of Iron in Brain Structures of Children with Sickle Cell Disease and Transfusion Hemosiderosis

R. Clark Brown, MD PhD, Deqiang Qiu, PhD, Laura Hayes, MD, Vaughn Barry, PhD MPH, Richard Jones, PhD

Blood (2014) 124 (21): 1393.

https://doi.org/10.1182/blood.V124.21.1393.1393

Published: 2014

Journal Articles

A Quick, Robust Protocol for Liver Iron Quantitation on 3.0 Tesla MRI Scanners

R. Clark Brown, MD PhD, Mitchell Turner, Binjian Sun, PhD, Richard Jones, PhD

Blood (2014) 124 (21): 4069.

https://doi.org/10.1182/blood.V124.21.4069.4069

Published: 2014

Journal Articles

Bone Turnover Biomarkers Are Useful In Monitoring Myeloma Bone Disease and As Early Predictor Biomarkers For Relapse Disease In Multiple Myeloma

Kay Reen Ting, MB Bch BAO, Abdul Hameed, MBBS, MRCP, Jennifer Brady, Paul Dowling, PhD, Colin Clarke, PhD, Justine Meiller, Constantine S. Mitsiades, MD, PhD, Paul G. Richardson, MD, Kenneth C. Anderson, MD, Martin Clynes, PhD, Peter O'Gorman, MD, PhD

Blood (2013) 122 (21): 1869.

https://doi.org/10.1182/blood.V122.21.1869.1869

Published: 2013

Journal Articles

Comparison Of Allogeneic Hematopoietic Cell Transplantation Versus Chemotherapy In Patients With Acute Myeloid Leukemia In First Remission

Xiaoyu Lai, Mingyu Zhu, Yi Luo, Yamin Tan, Weiyan Zheng, M.D., Yuanyuan Zhu, Jimin Shi, He Huang, MD, PhD.

Blood (2013) 122 (21): 5546.

https://doi.org/10.1182/blood.V122.21.5546.5546

Published: 2013

Journal Articles

The Clinical Utility Of Bone Turnover Markers In The Evaluation Of Bone Disease In Patients With Haemophilia A and B

Panagiotis Anagnostis, MD, PhD, Sofia Vakalopoulou, MD, PhD, Vyzantiadis Timoleon-Achilleas, MD, PhD, Maria Charizopoulou, Eudokia M. Mandala, Alexandra Agapidou, MD, Violaki Vassiliki, MD, Garipidou Vasilia, MD, PhD

Blood (2013) 122 (21): 3612.

https://doi.org/10.1182/blood.V122.21.3612.3612

Published: 2013

NARROW

Bone and Joint Health Markers in Persons with Hemophilia A (PwHA) Treated with Emicizumab in HAVEN 3

Impact of Daratumumab Monotherapy on Bone Parameters in Patients with Relapsed and/or Refractory Multiple Myeloma Who Have Received at Least 2 Prior Lines of Therapy Including Lenalidomide and a Proteasome Inhibitor; Interim Analysis of a Phase 2 Study (the REBUILD Study)

Bortezomib Overcomes Poor Prognosis Conferred By High Sictp in Untreated Plasma Cell Disorders

Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Phase 1 Study

Exosomes Play a Key Role in Multiple Myeloma Bone Disease and Tumor Development

Decreased Skeletal Health Negatively Impacts Quality of Life of People with Hemophilia

A Novel Ex-Vivo Model of Prolonged Osteoblast Suppression in Multiple Myeloma

Navigating the Changing Multiple Myeloma (MM) Treatment Landscape: Real-World Data on Clinical Practice Patterns in 287 MM Patients Treated in and Outside German DSMM (Deutsche Studiengruppe Multiples Myelom) Study Group Trials

Clinical Predictors of Venous Thromboembolism during Therapy for Childhood Acute Lymphoblastic Leukemia

Assessment of the Parameters of Myeloma Bone Disease Signaling to the Extent of Skeletal Involvement, Bone Mineral Turnover and Activity of Multiple Myeloma

The Clinical Utility of Bone Resorption and Bone Formation Markers in Multiple Myeloma

Differential Diagnosis of Hereditary and Acquired Thrombocytopenia By the Immature Platelet Fraction and Thrombopoietin Levels

Retrospective Analysis of Minimal Residual Disease-Guided Preemptive Treatment in Patients with AML and MDS - the SAL Study Group Experience

The Role of RANKL/Osteoprotegerin and Wnt Signaling Pathways in the Development of Osteoporosis in Patients with Hemophilia

Differential Influence of Lung Cancer Stage, Time from Diagnosis and Chemotherapy on Plasma and Cellular Biomarkers of Hypercoagulability. the Roadmap Study

Quantitation of Iron in Brain Structures of Children with Sickle Cell Disease and Transfusion Hemosiderosis

A Quick, Robust Protocol for Liver Iron Quantitation on 3.0 Tesla MRI Scanners

Bone Turnover Biomarkers Are Useful In Monitoring Myeloma Bone Disease and As Early Predictor Biomarkers For Relapse Disease In Multiple Myeloma

Comparison Of Allogeneic Hematopoietic Cell Transplantation Versus Chemotherapy In Patients With Acute Myeloid Leukemia In First Remission

The Clinical Utility Of Bone Turnover Markers In The Evaluation Of Bone Disease In Patients With Haemophilia A and B

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only